WTFC vs BIO.B
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
WTFC · Wintrust Financial$151.27 ▼ 0.30%
BIO.B · Bio-Rad Laboratories-B$379.50 ▲ 0.00%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- WTFC +16.6%
- BIO.B +24.3%
Head to head
| Metric | WTFC | BIO.B |
|---|---|---|
| Price | $151.27 | $379.50 |
| Change today | ▼ 0.30% | ▲ 0.00% |
| Market cap | $10.21B | $10.21B |
| Return, 3 months | -4.6% | +12.6% |
| Return, year to date | +9.7% | +22.1% |
| Return, 1 year | +17.5% | +24.3% |
| P/E (TTM) | 11.6 | 10.1 |
| P/B | 1.5 | 1.3 |
| P/E percentile vs own 5y | 48th | 96th |
| Dividend yield | 1.42% | – |
| Revenue growth (YoY, latest qtr) | +8.6% | -0.1% |
| Net profit growth (YoY) | +10.5% | +16.9% |
| Gross margin | – | 51.9% |
| Operating margin | – | 8.7% |
| Net margin | 30.4% | 8.6% |
| Return on equity | 13.2% | 3.1% |
| Analyst target vs. price | +16.8% | – |
| Analyst buy share | 82% | – |
| RSI (14) | 54 | 97 |
| 30-day volatility | 21.9% | 12.0% |
| Max drawdown, 1 year | -19.3% | -20.4% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- WTFC is the largest of the group by market value.
- BIO.B has returned the most over the past year.
- BIO.B carries the lowest trailing P/E.
- WTFC is growing revenue fastest.
- WTFC keeps the most profit per dollar of sales.
- BIO.B has been the calmest stock over the last 30 days.